J&J announces USFDA approval of IMBRUVICA

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) ...

January 29, 2019 | Tuesday | News
Basilea announces collaboration with Roche

Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche ...

January 25, 2019 | Friday | News
Wren Therapeutics completes £18M Series A Financing

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases ...

January 23, 2019 | Wednesday | News
AbbVie provides update on Phase 3 Study of IMBRUVICA

AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-113...

January 22, 2019 | Tuesday | News
Everest Medicines signs new deal targeting drug resistance

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...

January 14, 2019 | Monday | News
Janssen submits application to EMA seeking approval of STELARA

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation ...

January 11, 2019 | Friday | News
Denali Therapeutics announces Phase 1B Study of DNL747

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurode...

January 11, 2019 | Friday | News
Japan approves Amgen's osteoporosis drug

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...

January 10, 2019 | Thursday | News
Daiichi Sankyo receives regulatory approval for hypertension tablets

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...

January 10, 2019 | Thursday | News
Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy

Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and s...

January 9, 2019 | Wednesday | News
Oculis raises CHF 15.5 million

Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently ...

January 8, 2019 | Tuesday | News
AbbVie and Tizona Therapeutics announce strategic collaboration

Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, s...

January 4, 2019 | Friday | News
Bristol-Myers Squibb’s Sprycel® tablets now approved for pediatric patients

Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for&n...

January 4, 2019 | Friday | News
AstraZeneca announces phase III trials for roxadustat

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...

January 3, 2019 | Thursday | News
Lupin gets FDA approval for Clobazam oral suspension

Pharma major Lupin announced that it has received approval for its Clobazam Oral Suspension, 2.5 mg/mL from the United S...

January 1, 2019 | Tuesday | News
Teva brings Generic Elidel Cream, 1% in US market

Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Elidel®1 (pimecrolimus)...

January 1, 2019 | Tuesday | News
BeiGene initiates clinical trial of Tislelizumab with cancer patients

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...

December 31, 2018 | Monday | News
Chugai obtains approval for Genomic Mutation Analysis Program

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...

December 27, 2018 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls